Settlement Reached Between FEI, Show Jumper Paige Johnson

Johnson’s horse Luke Skywalker 46 tested positive for the local anesthetic pramoxine in January.
Share
Favorite
Close

No account yet? Register

ADVERTISEMENT

The Court of Arbitration for Sport (CAS) has approved a settlement between the Fédération Equestre Internationale (FEI) and U.S. jumper Paige Johnson in a substance reclassification case.

Samples taken Jan. 21, from the horse Luke Skywalker 46, ridden by Johnson at the CSI2* in Wellington, Florida, tested positive for the local anesthetic pramoxine. Following the FEI’s Tribunal’s decision to suspend Johnson for a year, the rider appealed to the CAS. 

As pramoxine will to be reclassified from a banned substance to controlled medication, effective from Jan. 1, 2018, the Johnson and the FEI ultimately agreed a settlement, which the CAS approved. Additional details on the decision are available online.

Under the terms of the settlement, the athlete’s period of ineligibility has been reduced from one year to three months, from April 5, 2017 (the date of notification) until July 5. Therefore, Johnson is now cleared to compete

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.

Share

Written by:

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

Where do you primarily feed your horse?
328 votes · 328 answers

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!